Invictus MD Strategies Appoints George E. Kveton to Board of Directors.

Invictus MD (CNX:IMH) – Mr. Kveton is a highly effective, strategic and pragmatic international executive and investment professional, with broad experience operating in both Fortune 500 and start-up environments. He has a proven record in generating top-line growth by executing cross-border merger and acquisition deals and transformations to a high standard, and in developing new profit streams in regulated industries.
He is currently one of the founding partners of Logscale Venture Partners, a firm focused on early- and growth-stage companies in the health care space. Operating out of Switzerland, Mr. Kveton provides investors with early exposure to disruptive innovations/technologies in pharma, medtech, biotechnology and life science, and in the adjacent fields of personalized medicine, diagnostics and e-health. He has in-depth strategic and corporate development experience of the fast-moving consumer goods and has had extensive involvement with leading consultancy companies.
With over 20 years of deal-making experience, Mr. Kveton has worked for leading tobacco players. As vice-president, business development, at Japan Tobacco International (JTI) he led several M&A transactions valued at $1.5-million (U.S.), and was appointed by the chief executive officer to expand JTI’s presence in the United States and Latin America, with parallel responsibility for deal origination and execution in the area of emerging products. Formerly while at Philip Morris International, he led two major acquisitions (up to $1-billion (U.S.)), readied businesses in Poland, Hungary, Czech and Slovak Republics for European Union accession, and facilitated new market entries into Croatia and neighbouring countries. His multibillion-dollar private and public company deal sheet is global, spanning five continents.
A graduate of Queen’s University in Canada, and executive programs at U.C. Berkeley Haas School of Business and Harvard Business School, Mr. Kveton is an active angel investor and a true partner to entrepreneurs, bringing stewardship and management depth to their businesses.
“George is an outstanding addition to the board, bringing extensive global business development, finance and acquisition experience, and further enhancing our board,” said Dan Kriznic, chairman and chief executive officer. “His international network and reputation, along with his valuable knowledge and sound judgment, will serve the company and our shareholders well, as we continue on our journey of rapid growth, which includes expanding our production capacity and further establishing our leadership position as Canada’s cannabis company.”
“I am delighted to join Invictus MD and to become part of this truly dynamic team that will continue to provide leadership in the burgeoning cannabis sector,” said Mr. Kveton. “This company has captivated me in terms of its rapid growth, management and board strength, disciplined execution of its strategic plan, and vision for the future of the industry. I look forward to contributing to Invictus MD’s strategic decision making.”
About Invictus MD Strategies Corp.
Invictus MD Strategies is focused on three main verticals within the burgeoning Canadian cannabis sector: licensed producers under the cannabis for medical purposes regulations (ACMPR); fertilizer and nutrients through Future Harvest Development Ltd.; and cannabis data and delivery, with its wholly owned subsidiary Poda Technologies Ltd.
Click here to connect with Invictus MD (CNX:IMH) to receive an Investor Presentation.